FDA postpones orthopedic devices panel on shortwave diathermy devices

April 5, 2013 by Arezu Sarvestani

Scheduling conflicts delay the FDA's Orthopaedic & Rehabilitation Devices Panel, during which the agency was planning to discuss a possible reclassification of shortwave diathermy devices.

FDA logo

The FDA's Orthopaedic & Rehabilitation Devices Panel postponed today's meeting over scheduling conflicts that meant key players couldn't attend.

The meeting was convened to discuss a possible reclassification of shortwave diathermy devices, which are used to therapeutically heat tissue with an electric current with applications in joint inflammation treatments and physiotherapy.

Sign up to get our free newsletters delivered right to your inbox.

The FDA is considering pushing shortwave diathermy devices to Class III status, to require premarket approval.

The federal watchdog agency hasn't announced a new meeting date, but said it will issue a notice in the Federal Register when a new appointment as been made.


Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp